Researchers Use New Tool To Counter Multiple Myeloma Drug Resistance
9/10/2011
"Acquired drug resistance" (ADR) is a major problem encountered in treating some forms of cancer. The ability to monitor the proteins involved in drug resistance has been a hurdle facing cancer researchers...
Novel Approach Scores First Success Against Elusive Cancer Gene
9/10/2011
Dana-Farber Cancer Institute scientists have successfully disrupted the function of a cancer gene involved in the formation of most human tumors by tampering with the gene's "on" switch and growth signals, rather than targeting the gene itself...
Nearly 50,000 Americans are diagnosed each year with stage III or locally advanced NSCLC, for which surgery is usually not a viable treatment option. Optimizing nonsurgical treatment strategies for these patients is an ongoing research endeavor...
HPV Vaccine Cervarix, Two Doses As Good As Three After Four Years
9/09/2011
Two doses of Cervarix, an HPV (human papillomavirus) vaccine were found to be as effective in protecting females from HPV types 16 and 18, which account for 70% of cervical cancer cases, as the standard three doses over a four-year period, researchers have reported in The Journal of the National Cancer Institute...
HPV Vaccine Cervarix, Two Doses As Good As Three After Four Years
9/09/2011
Two doses of Cervarix, an HPV (human papillomavirus) vaccine were found to be as effective in protecting females from HPV types 16 and 18, which account for 70% of cervical cancer cases, as the standard three doses over a four-year period, researchers have reported in The Journal of the National Cancer Institute...
Link Found Between Biological Agents For Rheumatoid Arthritis And Greater Skin Cancer Risk
9/09/2011
A systematic review published in the Annals of the Rheumatic Diseases suggests, that biological agents used for the treatment of rheumatoid arthritis seem to be linked with an increased risk of skin cancer...
Marshall Edwards, Inc. (Nasdaq: MSHL), an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the initiation of a Phase I clinical trial of the Company's lead drug candidate ME-143 in patients with refractory solid tumors...
Chemotherapy Is As Effective Before Breast Cancer Surgery As After
9/09/2011
Whether chemotherapy is given before or after breast-conserving therapy (BCT) does not have an impact on long-term local-regional outcomes, suggesting treatment success is due more to biologic factors than chemotherapy timing, according to a study by researchers at The University of Texas MD Anderson Cancer Center...
Nanosensors Made From DNA May Light Path To New Cancer Tests And Drugs
9/09/2011
Sensors made from custom DNA molecules could be used to personalize cancer treatments and monitor the quality of stem cells, according to an international team of researchers led by scientists at UC Santa Barbara and the University of Rome Tor Vergata...
'TF Beacons' May Light Path To New Cancer Tests And Drugs
9/09/2011
Scientists are reporting development of a long-sought new way to detect the activity of proteins that bind to the DNA in genes, often controlling the activity of genes in ways that make cells do everything from growing normally to becoming cancerous. Their report appears in the Journal of the American Chemical Society...